Largest pharmaceutical companies in Switzerland by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Novartis leads the 2 pharmaceutical companies in Switzerland ranked by net assets, at $46.1B, ahead of BeOne Medicines ($4.4B). Figures as of 18 Nov 2026, 20:27 UTC, from Yahoo Finance quotes.

Only 2 companies have this figure here, too few to make a ranking, so this list is not offered to search engines.

Key facts

Companies ranked
2
First
Novartis$46.1B
Combined market value
$339.5B
Countries
1

Market values as of .

Switzerland
All sectors
Pharmaceuticals
USD
Clear filters
Largest pharmaceutical companies in Switzerland by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1NovartisNVS · Health Care$46.1B$293.4B$155.33 2.39% down 25% up Switzerland
2BeOne MedicinesONC · Health Care$4.4B$46.2B$404.14 2.21% down 17% up Switzerland

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceutical companies in Switzerland rank first by net assets?

Novartis ($46.1B) and BeOne Medicines ($4.4B) are the top two of the 2 pharmaceutical companies in Switzerland ranked by net assets as of 18 Nov 2026, 20:27 UTC.

How many pharmaceutical companies in Switzerland are in this ranking?

2 are ranked by net assets.

What are these pharmaceutical companies in Switzerland worth together?

The 2 pharmaceutical companies in Switzerland ranked by net assets have a combined market value of $339.5B as of 18 Nov 2026, 20:27 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest pharmaceutical companies in Switzerland by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=switzerland&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.